InvestorNewsBreaks - Cybin Inc. (NEO: CYBN) (OTCQB: CLXPF) Receives Listing Approval from NYSE American

(Investor Brand Network via Comtex)

Cybin (NEO: CYBN) (OTCQB: CLXPF), a biotechnology company focused on progressing psychedelic therapeutics, will be moving exchanges. The company has announced that it received conditional listing approval from the NYSE American LLC stock exchange. The NYSE American is designed for growing companies and offers investors a variety of ways in which to trade. The exchange is a competitively priced venue that blends unique features derived from the NYSE, such as electronic Designated Market Makers ("e-DMMs") with quoting obligations for each NYSE American-listed company, with NYSE Arca's fully electronic price/time priority execution model. The company noted in making the announcement that any listing is subject to the approval of the NYSE American and that all applicable regulatory requirements must be met. Cybin anticipates maintaining its listing on the NEO Exchange even after moving to the NYSE American exchange, where it will trade using the ticker CYBN. "Conditional listing approval on the NYSE American is an important milestone in Cybin's growth journey," said Cybin CEO Doug Drysdale. "We expect expanded access to investors to further fuel our mission to develop revolutionary psychedelic therapeutics for patients suffering from mental health conditions."

To view the full press release, visit https://ibn.fm/5KujE

About Cybin Inc.

Cybin is a leading biotechnology company focused on progressing psychedelic therapeutics by utilizing proprietary drug-discovery platforms, innovative drug delivery systems, novel formulation approaches and treatment regimens for psychiatric disorders. For more information, visit the company's website at www.Cybin.com.

NOTE TO INVESTORS: The latest news and updates relating to CYBN are available in the company's newsroom at https://ibn.fm/CYBN

About InvestorWire

InvestorWire is the wire service that gives you more. From regional releases to global announcements presented in multiple languages, we offer the wire-grade dissemination products you'll need to ensure that your next press release grabs the attention of your target audience and doesn't let go. While our competitors look to nickel and dime you with hidden fees and restrictive word limits, InvestorWire keeps things transparent. We offer UNLIMITED Words on all domestic releases. While other wire services may provide a basic review of your release, InvestorWire helps you put your best foot forward with complimentary Press Release Enhancement.

With our competitors, the work is done the second your release crosses the wire. Not with InvestorWire. We include follow-up coverage of every release by leveraging the ever-expanding audiences of the 50+ brands that make up the InvestorBrandNetwork.

Get more out of your next press release with InvestorWire. It's unlike anything you've seen before.

For more information, please visit https://www.InvestorWire.com

Please see full terms of use and disclaimers on the InvestorBrandNetwork website applicable to all content provided by IBN, wherever published or re-published: http://ibn.fm/Disclaimer

InvestorWire (IW)
8033 Sunset Blvd Suite 1037-IW
Los Angeles, CA 90046
310.299.1717 Office
www.InvestorWire.com
[email protected]

InvestorWire is part of the InvestorBrandNetwork.

comtex tracking

COMTEX_390240788/2557/2021-07-22T09:49:13